Search

Your search keyword '"Chaudhry, Amina"' showing total 25 results
Start Over Author "Chaudhry, Amina" Publication Year Range Last 10 years
25 results on '"Chaudhry, Amina"'

2. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

Author

Epperla, Narendranath, Zayac, Adam S., Landsburg, Daniel J., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy, Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, Mohammad Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin, Bond, David A., Evens, Andrew M., Naik, Seema G., Kamdar, Manali, Haverkos, Bradley M., Karmali, Reem, Farooq, Umar, Vose, Julie M., Rubinstein, Paul, Chaudhry, Amina, and Olszewski, Adam J.

Published
2024
Full Text
View/download PDF

4. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Author

Zayac, Adam S., Landsburg, Daniel J., Hughes, Mitchell E., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy K., Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Stepanovic, Adam, Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, M. Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin H., Epperla, Narendranath, Bond, David A., Farooq, Umar, Saad, Mahak, Evens, Andrew M., Pandya, Karan, Naik, Seema G., Kamdar, Manali, Haverkos, Bradley, Karmali, Reem, Oh, Timothy S., Vose, Julie M., Nutsch, Heather, Rubinstein, Paul G., Chaudhry, Amina, and Olszewski, Adam J.

Published
2023
Full Text
View/download PDF

8. High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series

Author

Epperla, Narendranath, primary, Zayac, Adam, additional, Landsburg, Daniel J., additional, Hughes, Mitchell, additional, Bock, Allison M., additional, Nowakowski, Grzegorz S., additional, Ayers, Emily C., additional, Girton, Mark, additional, Hu, Marie, additional, Beckman, Amy, additional, Li, Shaoying, additional, Medeiros, L. Jeffrey, additional, Chang, Julie E., additional, Stepanovic, Adam, additional, Kurt, Habibe, additional, Sandoval-Sus, Jose, additional, Ansari-Lari, M. Ali, additional, Kothari, Shalin K., additional, Kress, Anna, additional, Xu, Mina L, additional, Torka, Pallawi, additional, Sundaram, Suchitra, additional, Smith, Stephen D, additional, Naresh, Kikkeri N, additional, Karimi, Yasmin, additional, Bond, David A., additional, Farooq, Umar, additional, Saad, Mahak, additional, Evens, Andrew Matthew, additional, Pandya, Karan, additional, Naik, Seema G, additional, Kamdar, Manali, additional, Haverkos, Bradley M., additional, Karmali, Reem, additional, Oh, Timothy S, additional, Vose, Julie M., additional, Nutsch, Heather, additional, Rubinstein, Paul, additional, Chaudhry, Amina, additional, and Olszewski, Adam J., additional

Published
2022
Full Text
View/download PDF

11. High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Characteristics, Treatment, and Outcomes from 17 Academic US Centers

Author

Zayac, Adam, primary, Landsburg, Daniel J, additional, Hughes, Mitchell, additional, Ayers, Emily C., additional, Girton, Mark, additional, Hu, Marie, additional, Beckman, Amy, additional, Li, Shaoying, additional, Medeiros, L. Jeffrey, additional, Kurt, Habibe, additional, Sandoval-Sus, Jose, additional, Ansari-Lari, M. Ali, additional, Kothari, Shalin K., additional, Kress, Anna, additional, Xu, Mina L., additional, Torka, Pallawi, additional, Sundaram, Suchitra, additional, Smith, Stephen D., additional, Naresh, Kikkeri N, additional, Karimi, Yasmin, additional, Epperla, Narendranath, additional, Bond, David A., additional, Evens, Andrew M., additional, Pandya, Karan, additional, Naik, Seema G, additional, Kamdar, Manali, additional, Haverkos, Brad, additional, Karmali, Reem, additional, Seijung Oh, Timothy, additional, Vose, Julie M., additional, Nutsch, Heather, additional, Rubinstein, Paul, additional, Chaudhry, Amina, additional, and Olszewski, Adam J., additional

Published
2021
Full Text
View/download PDF

14. Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancer

Author

Jain, Amit L., primary, Jamy, Omer, additional, Mullins, Janice, additional, Usman, Rana Muhammad, additional, Hare, Felicia, additional, Valasareddy, Poojitha, additional, Chaudhry, Amina, additional, Ryder, Julie, additional, Smith, Justin R., additional, Miller, Emily, additional, Ranganath, Harsha, additional, Schwartzberg, Lee, additional, Stepanski, Edward, additional, Walker, Mark, additional, Gatwood, Justin, additional, and Vidal, Gregory A., additional

Published
2020
Full Text
View/download PDF

15. Outcomes with CDK4/6 inhibitors based on endocrine sensitivity in hormone receptor-positive metastatic breast cancer (HR+ MBC).

Author

Jain, Amit L, primary, Mullins, Janice Nhan, additional, Poorman, Kelsey Anne, additional, Chaudhry, Amina, additional, Ranganath, Harsha Avinash, additional, Miller, Emily McCollum, additional, Valasareddy, Poojitha, additional, Smith, Justin R, additional, Ryder, Julie, additional, Winerip, Michelle, additional, Schwartzberg, Lee S., additional, and Vidal, Gregory A., additional

Published
2019
Full Text
View/download PDF

22. HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers

Author

Mayer, Kenneth H., primary, Crawford, Phil, additional, Dant, Lydia, additional, Gillespie, Suzanne, additional, Singal, Robbie, additional, Vandermeer, Meredith, additional, Muench, John, additional, Long, Tim, additional, Quach, Thu, additional, Chaudhry, Amina, additional, Crane, Heidi M., additional, Lembo, Daniela, additional, Mills, Robert, additional, and McBurnie, Mary Ann, additional

Published
2016
Full Text
View/download PDF

24. Transcription factor binding site divergence across maize inbred lines drives transcriptional and phenotypic variation.

Author

Galli M, Chen Z, Ghandour T, Chaudhry A, Gregory J, Li M, Zhang X, Dong Y, Song G, Walley JW, Chuck G, Whipple C, Kaeppler HF, Huang SC, and Gallavotti A

Abstract

Regulatory elements are important constituents of plant genomes that have shaped ancient and modern crops. Their identification, function, and diversity in crop genomes however are poorly characterized, thus limiting our ability to harness their power for further agricultural advances using induced or natural variation. Here, we use DNA affinity purification-sequencing (DAP-seq) to map transcription factor (TF) binding events for 200 maize TFs belonging to 30 distinct families and heterodimer pairs in two distinct inbred lines historically used for maize hybrid plant production, providing empirical binding site annotation for 5.3% of the maize genome. TF binding site comparison in B73 and Mo17 inbreds reveals widespread differences, driven largely by structural variation, that correlate with gene expression changes. TF binding site presence-absence variation helps clarify complex QTL such as vgt1 , an important determinant of maize flowering time, and DICE, a distal enhancer involved in herbivore resistance. Modification of TF binding regions via CRISPR-Cas9 mediated editing alters target gene expression and phenotype. Our functional catalog of maize TF binding events enables collective and comparative TF binding analysis, and highlights its value for agricultural improvement.

Published
2024
Full Text
View/download PDF

25. Usefulness of patient-reported outcomes to assess the effectiveness of topical hormonal therapy for gynecologic symptoms after antihormonal treatment for breast cancer.

Author

Jain AL, Jamy O, Mullins J, Usman RM, Hare F, Valasareddy P, Chaudhry A, Ryder J, Smith JR, Miller E, Ranganath H, Schwartzberg L, Stepanski E, Walker M, Gatwood J, and Vidal GA

Abstract

The aim of this retrospective study was to assess the efficacy of topical hormonal therapy (THT) to relieve vaginal symptoms resulting from antihormonal therapy in women with hormone receptor-positive breast cancer. A total of 74 breast cancer patients who received THT for vaginal complaints were retrospectively identified and statistically matched with 74 control breast cancer patients with vaginal complaints with no documented use of THT. Symptom scores were recorded from the center's proprietary patient-reported outcomes database, Patient Care Monitor (ConcertoHealthAI, Boston). A baseline score was noted at the initiation of antihormonal therapy and was followed at 6 and 12 months. The median differences between baseline, 6-month, and 12-month scores were analyzed. Repeated measures analysis of variance assessed the impact of topical hormonal replacement. There was no statistically significant difference in score change between the two groups at 6 and 12 months. In the active THT group, there were no statistically significant differences in vaginal complaints or sexual problems over time: { F (2, 146) = 0.99, P  = 0.369; and F (2, 146) = 1.56, P = 0.217 }, respectively. In this study, the use of topical hormonal replacement was not effective in alleviating vaginal symptoms., (Copyright © 2020 Baylor University Medical Center.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results